This $500,000 Project Grant awarded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program aims to study the relationships between diagnosis quality, time constraints, and clinician stress. The key products and services to be delivered under this grant include: 1) Collecting feedback from 400 patients on their diagnostic experiences, 2) Analyzing EMR data from 40,000 visits to examine the links between clinician...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $778,551 to The Rand Corporation to conduct research on disparities in undiagnosed and misdiagnosed dementia, including Alzheimer's disease and related dementias (AD/ADRD), and the impact on healthcare utilization and costs. The key objectives are to: 1) Develop a novel probabilistic method to classify AD/ADRD status among over 10 million Medicare beneficiaries, 2) Estimate the impact of...
This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop person-centered outcome measures for assessing the quality of goal-directed care for individuals with serious mental illnesses (SMI) such as schizophrenia and bipolar disorder. The $639,417 award, with a project period from September 1, 2024 to June 30, 2028, supports a research team from the National Committee for Quality...
This federal Project Grant award, funded under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program by the Agency for Healthcare Research and Quality (AHRQ), aims to reduce variation and disparities in radiologist recommendations for additional imaging (RAI) in head and neck radiology. The $795,826 award to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, will fund a 5-year research project to: 1) Identify sociodemographic...
This $877,297 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a comprehensive study to map the capacity, equity, and impact of the U.S. mental health emergency response system (MHERS). The key products to be delivered include: 1) a longitudinal, nationally-representative inventory of each state's MHERS resources, such as acute psychiatric beds and 988 crisis hotline staffing; 2) analyses examining...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $689,268 to The RAND Corporation to conduct a mixed-methods study on the implementation and impacts of Certified Community Behavioral Health Clinics (CCBHCs) in New York State. The study has three components: 1) Assessing CCBHC implementation through qualitative interviews, clinic surveys, and administrative data; 2) Investigating service...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $1,111,596.00 to Kaiser Foundation Hospitals to evaluate and improve outcome-focused quality measures for depression and anxiety treatment. The project aims to identify patient characteristics that lead to biases in existing quality measures, adjust the measures to account for population differences, and develop proposals for improved...
The National Institute of Mental Health (NIMH) awarded a $1,647,117 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of California, Los Angeles (UCLA) to develop, test, and validate a new, transdiagnostic outcome-focused measure of mental health care quality. This measure will be based on routine patient-reported symptoms, allowing for aggregation at the provider, clinic, organization, or plan level to inform treatment choices, improve service delivery, and reduce...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) totaling $729,367 will study the impacts of a 2022 nationwide shortage of immediate-release formulations of amphetamine mixed salts (a class of prescription stimulant medications) on youth with Attention-Deficit Hyperactivity Disorder (ADHD). The research aims to: 1) measure the "amphetamine gap" and "stimulant gap" in communities and...
This federal Project Grant award from the Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program provides $1,000,000 to the Regents of the University of Michigan to conduct research aimed at preventing and mitigating the impact of sexual harassment on physician well-being. The key goals of the 4-year project, titled "ADDRESSING INSTITUTIONAL SEXUAL HARASSMENT TO IMPROVE...